Brief: Polyphor Temporarily Halts Enrollment In Phase III Studies Of Murepavadin

Spexis AG

09/05/2019 17:13

May 9 (Reuters) - Polyphor AG  POLN.S :
    * POLYPHOR TEMPORARILY HALTS ENROLLMENT IN PHASE III STUDIES
OF
MUREPAVADIN FOR TREATMENT OF PATIENTS WITH NOSOCOMIAL PNEUMONIA

Source text for Eikon:  ID:nEQ4GnjwXa 
Further company coverage:  POLN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))